Skip to Main Content

Paper Details

Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
Ann Surg Oncol
0
2023
5-FU, Cancer, Colon Cancer, Dukes' B2 colon cancer, Dukes' B2 disease, Dukes' B3 and C disease, Patients, colon cancer, fluorouracil, patients
Author NameAffiliation
Margaret KemenyIcahn School of Medicine at Mount Sinai, Queens Cancer Center of NYC Health + Hospitals/Queens
Al B BensonNorthwestern University
  • 1 - 2

Datasets

Release 1.2